NCT00770796View on ClinicalTrials.gov

Statins for Prevention of Contrast Induced Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Contrast Induced Nephropathy
Interventions
DRUG

Atorvastatin

80 mg die

DRUG

Placebo

All Listed Sponsors
lead

Ospedale Misericordia e Dolce

OTHER

NCT00770796 - Statins for Prevention of Contrast Induced Nephropathy | Biotech Hunter | Biotech Hunter